AG
ABEO icon

Advisor Group’s Abeona Therapeutics ABEO Stock Holding History

Advisor Group’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-20
Closed -$8K – 5083
2018
Q2 		$8K Hold
20
– – ﹤0.01% 4167
2018
Q1 		$7K Hold
20
– – ﹤0.01% 4250
2017
Q4 		$8K Hold
20
– – ﹤0.01% 4192
2017
Q3 		$9K Hold
20
– – ﹤0.01% 4026
2017
Q2 		$3K Hold
20
– – ﹤0.01% 4391
2017
Q1 		$3K Hold
20
– – ﹤0.01% 4270
2016
Q4 		$2K Sell
20
-100
-83% -$15.7K ﹤0.01% 4190
2016
Q3 		$18K Buy
+120
New +$11.7K ﹤0.01% 3204
2016
Q2 		– Hold
0
– – – 4378

Other funds holding ABEO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Advisor Group's ABEO Position: Q3 2018 in Review

Advisor Group sold out of Abeona Therapeutics (ABEO) in Q3 2018, closing a stake of 20 shares — an estimated $8K sold.

Advisor Group first reported a position in ABEO in Q3 2016 and held it in 8 quarters. The position peaked at $18K in Q3 2016. 104 funds tracked by Wall St. Rank hold ABEO as of Q3 2018.

  • Advisor Group reported no remaining Abeona Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Advisor Group sold 20 Abeona Therapeutics shares in Q3 2018, an estimated $8K.
  • Advisor Group first reported a position in Abeona Therapeutics in Q3 2016 and held it in 8 quarters.
  • Advisor Group's Abeona Therapeutics position peaked at $18K in Q3 2016.
  • 104 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2018.

Based on Advisor Group's 13F filing for Q3 2018, filed 14 Nov 2018.